Johnson & Johnson has been ordered to pay $4.7bn (£3.6bn) in damages to 22 women who alleged that its talc products caused them to develop ovarian cancer.

Johnson & Johnson on Tuesday won the reversal of a $72 million verdict in favor of the family of a woman whose death from ovarian cancer they claimed stemmed from her use of the company’s talc-based products

 A California jury on Monday ordered Johnson & Johnson to pay $417 million to a woman who claimed she developed ovarian cancer after using the company's talc-based products 

Johnson & Johnson is seizing upon a U.S. Supreme Court ruling from Monday limiting where injury lawsuits can be filed to fight off claims it failed to warn women that talcum powder could cause ovarian cancer.

 Diversified healthcare company Johnson & Johnson said on Wednesday its experimental flu drug significantly reduced the presence of the virus in patients with a type of influenza in a mid-stage study.

 California has accused Johnson & Johnson of failing to warn doctors and patients about the severity and frequency of complications associated with its pelvic mesh devices.

 A U.S. jury verdict linking regular use of Johnson & Johnson talcum powder to a woman's death from ovarian cancer has spurred new concern from consumers, but scientists say the evidence of real danger is inconclusive at best.

Global health care giant Johnson & Johnson and its subsidiaries have agreed to pay more than 2.2 billion U.S. dollars to resolve criminal and civil investigations for misbranding antipsychotic drugs and paying kickbacks to pharmacists,